Meridian Bioscience CEO Jack Kenny's 2021 pay slips 3% to $3.2M
Meridian Bioscience reports 2021 executive compensation
By ExecPay News
Published: December 15, 2021
Meridian Bioscience reported fiscal year 2021 executive compensation information on December 15, 2021.
In 2021, four executives at Meridian Bioscience received on average a compensation package of $1.5M, a 3% increase compared to previous year.
Average pay of disclosed executives at Meridian Bioscience
Jack Kenny, Chief Executive Officer, received $3.2M in total, which decreased by 3% compared to 2020. 32% of Kenny's compensation, or $1M, was in stock awards. Kenny also received $800K in non-equity incentive plan, $690K in option awards, $690K in salary, as well as $19K in other compensation.
Lourdes G. Weltzien, Executive Vice President,, received a compensation package of $991K, which increased by 12% compared to previous year. 39% of the compensation package, or $384K, was in salary.
Bryan T. Baldasare, Chief Financial Officer, earned $953K in 2021, a 6% increase compared to previous year.
Life Science Tony Serafini-Lamanna, Executive Vice President, Diagnostics, received $901K in 2021, which increases by 15% compared to 2020.
Meridian Bioscience's fiscal year ends on September 30.
Related executives
You may also like
Source: SEC filing on December 15, 2021.